TCM
GRCL

TCG Crossover Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

TCG Crossover Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,514,786
Closed -$45.3M – 37
2023
Q4 		$45.3M Buy
4,514,786
+1,475,897
+49% +$14.8M 5.03% 9
2023
Q3 		$8.75M Buy
+3,038,889
New +$8.75M 1.29% 23